HomeProductsBioactive CompoundsPI3K/Akt/mTOR PathwayPI3KGsk-2292767
Chemical structure of CAS 1254036-66-2

Gsk-2292767

In Stock•Starting at $88 for 1 mg•Purity ≥ 98%
CAS No.1254036-66-2
MDL No.MFCD22572737
MFC24H28N6O5S
MW512.60
InChI KeyNLUPPCTVKHDVIQ-GASCZTMLSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$88In Stock
5 mg98%$285In Stock
10 mg98%$444In Stock
25 mg98%$972In Stock
50 mg98%$1675In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1254036-66-2
Product NameGsk-2292767
Heavy Atom Count36Rotatable Bond Count7
Atom Stereo Count2Bond Stereo Count0
HBA9HBD2
TPSA135.470 ŲCharge0
Exact Mass512.18419Complexity1487.94
pKa5.875XLogP3.269

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach.

Journal of medicinal chemistry • Vol. 61, Issue 24 • 2018
PMID: 30532965DOI: 10.1021/acs.jmedchem.8b01556

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.

Journal of medicinal chemistry • Vol. 58, Issue 18 • 2015
PMID: 26301626DOI: 10.1021/acs.jmedchem.5b00767

Evaluation of WO2012032067 and WO2012055846: two selective PI3Kδ inhibitors, which is GSK-2269557?

Expert opinion on therapeutic patents • Vol. 22, Issue 8 • 2012
PMID: 22765651DOI: 10.1517/13543776.2012.701281

Documentation